Questions for Will Spooren: Paving a path to autism drugs
A European initiative that aims to provide a framework for clinical trials in autism has developed tools to track treatment responses.
A European initiative that aims to provide a framework for clinical trials in autism has developed tools to track treatment responses.
The MacArthur Foundation honors neuroscientist Beth Stevens, and researchers pin down factors that influence the placebo effect in autism trials.
A $13 million grant from the National Institutes of Health aims to help to make stem cell models of autism, and the ‘unaffected sibling’ of a girl with autism pledges to advance the field.
A $28 million initiative aims to develop objective tools for tracking social skills in children with autism. The initiative’s leader outlines its approach.
Thomas Insel is stepping down as director of the National Institute of Mental Health after 13 years, and a policy aimed at curbing conflicts of interest is having little impact.
The debate about autism screening resurges, and psychologists want to blacklist the term “autism epidemic.”
The National Institutes of Health is reviving a defunct study that aimed to identify environmental risk factors for autism and other childhood disorders. Some researchers say the do-over is unlikely to live up to the original project’s promise.
Are scientists doing enough to communicate their findings — and explain their findings’ importance — to families affected by autism? The answer, suggests a new study, is no.
California might make vaccines mandatory, and religious figures may weigh in on the genetic engineering of embryos.
Young scientists face unprecedented challenges in transitioning from postdoctoral fellowships to tenured faculty positions. We asked researchers from different generations for solutions to the scientific career crisis.